Japan: Saisei Bioventures announces JIC as new LP and appoints Saito as partner

Japan Investment Corp (JIC) has become a limited partner (LP) in the Saisei Bioventures Fund with a US$30m investment. Saisei Fund, managed by Saisei Ventures, was established in January 2021 by Healios to invest in innovative biotechnology companies in Japan and the US developing transformative technologies in cell and gene therapy and regenerative medicine. Healios…

You must be a HMI Subscriber to view this content.

Subscribe Now »